New Alzheimer's drugs could require 'phased' NHS introduction

“There are only a few centres at the moment who could really give this drug effectively," says Professor Sir John Hardy (UCL Queen Square Institute of Neurology) about two new Alzheimer's drugs donanemab and lecanemab, adding that dementia care in the UK needs "a rethink."

Listen: BBC Radio 4 'Today' (from 1 hr 35 mins 50 secs), BBC Radio 2 'Vernon Kay' (from 30 mins 1 sec), Read: Telegraph (£)